Material and methods
respiratory distress, cholestasis
MULTIPLE CONGENITAL ANOMALIES, IUGR, CONGENITAL INFECTION, CHOLESTASIS
This randomized open-label clinical trial was carried out on 70 full-term neonates with IUGR who were referred to the neonatal intensive care unit (NICU), Pediatric Department, Tanta University Hospitals from June 2021 to January 2022. The trial was done after approval from the Ethical Committee of the Faculty of Medicine at Tanta University (code:35199/1/22). The trial was registered at clinicaltrials.gov (ID: NCT05242107). The guardians of included neonates provided informed consent.Exclusion criteria were preterm neonates, neonates who died before feeding was established, neonates with congenital infection, neonates with respiratory distress, neonates with cholestasis, and neonates who had multiple congenital anomalies.